Aspiriant LLC’s Blackstone BX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$375K Sell
3,348
-193
-5% -$25.3K 0.01% 277
2026
Q2
$417K Buy
3,541
+541
+18% +$65K 0.01% 273
2026
Q1
$345K Buy
3,000
+1,079
+56% +$140K 0.01% 263
2025
Q4
$296K Buy
1,921
+21
+1% +$3.19K 0.01% 282
2025
Q3
$325K Sell
1,900
-34
-2% -$5.82K 0.01% 241
2025
Q2
$289K Sell
1,934
-62
-3% -$8.52K 0.01% 262
2025
Q1
$279K Sell
1,996
-1,865
-48% -$303K 0.01% 245
2024
Q4
$666K Buy
3,861
+1,420
+58% +$247K 0.02% 171
2024
Q3
$374K Sell
2,441
-2
-0.1% -$277 0.01% 211
2024
Q2
$302K Sell
2,443
-210
-8% -$25.8K 0.01% 227
2024
Q1
$349K Buy
+2,653
New +$331K 0.01% 231

Other funds holding BX

Aspiriant LLC's BX Position: Q3 2026 in Review

Aspiriant LLC reduced its Blackstone (BX) stake by 5.5% in Q3 2026, selling an estimated $25.3K and leaving 3,348 shares worth $375K. The position accounts for 0.01% of the portfolio, ranked #277.

Aspiriant LLC first reported a position in BX in Q1 2024 and has held it in 11 quarters since. The position peaked at $666K in Q4 2024. 883 funds tracked by Wall St. Rank hold BX as of Q3 2026.

  • Aspiriant LLC held 3,348 shares of Blackstone worth $375K as of Q3 2026.
  • Aspiriant LLC sold 193 Blackstone shares in Q3 2026, an estimated $25.3K.
  • Blackstone made up 0.01% of Aspiriant LLC's portfolio in Q3 2026, its #277 holding.
  • Aspiriant LLC first reported a position in Blackstone in Q1 2024 and has held it in 11 quarters since.
  • Aspiriant LLC's Blackstone position peaked at $666K in Q4 2024.
  • 883 funds tracked by Wall St. Rank held Blackstone as of Q3 2026.

Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.